胆道闭锁
胆汁淤积
医学
新生儿胆汁淤积症
胃肠病学
新生儿肝炎
肝活检
内科学
活检
人口
黄疸
病理
肝移植
环境卫生
移植
作者
Aniket Halder,Sabita Patra,Bappa Mandal,Gautam Ray,Ranajoy Ghosh,Suchandra Mukherjee,Uttara Chatterjee
标识
DOI:10.4103/ijpm.ijpm_215_22
摘要
ABSTRACT Background: Cholestatic disorders are a significant cause of morbidity and mortality in infants. Characterization of these disorders and differentiating biliary atresia (BA) from other causes of intrahepatic cholestasis is an age-old problem. Objectives: To study the spectrum of different infantile cholestatic disorders in our population, to differentiate BA from other causes of neonatal cholestasis (NC) on a liver biopsy, and validation of the available scoring system for the characterization of these disorders. Materials and Methods: This is an observational cross-sectional study performed over a period of 3 years between 2018 and 2021, done on neonates and infants presenting with cholestatic jaundice. The changes on liver biopsy were evaluated by different histological parameters and available scoring systems to differentiate BA from non-BA causes. Correlation with clinical, biochemical, and imaging findings was done in all cases. Results: This study included 87 cases of NC, of which BA comprised 28 cases (32%), whereas idiopathic neonatal hepatitis (INH) comprised only 12 cases (14%). Portal neutrophilic inflammation ( P = 0.000053), ductal cholestasis ( P < 0.001), neoductular bile plugs ( P < 0.001) and bile ductular proliferation ( P < 0.0001) were significantly more in BA, whereas lobular lymphocytic inflammation ( P = 0.001) and giant cell transformation of hepatocytes ( P = 0.0024) were more frequent in the non-BA group. Using the Lee and Looi scoring system, a histologic score ≥7 was helpful in identifying BA with 85.7% sensitivity, 92.6% specificity, and 90.6% accuracy. Conclusion: BA is the commonest cause of NC in neonates, whereas the frequency of INH is declining. Detailed histomorphologic analysis of liver biopsy, aided with IHC, is the cornerstone for the diagnosis of these disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI